A comparison between cytological method and PCR in the diagnosis of HPV infection among patients with cervical cancer

Biotechnology

Volumn 7, Issue 4, 2008, Pages 798-802

  Moosavi, S Soghra ^a   Soltani, Saeed ^b   Shaikhpoor, Mojhgan ^c,d  

^a Khatam University   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c Faculty of Science   (Iran)

^d UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Cervical cancer; Cytological method; HPV infection; PCR

Indexed keywords

CERVICAL CANCER; CERVICAL CANCERS; CYTOLOGICAL METHOD; HPV INFECTION; HUMAN PAPILLOMAVIRUS; INFECTED PATIENTS; PCR; POLYMERASE CHAIN REACTION; REPRODUCTIVE SYSTEMS;

CYTOLOGY; DEVELOPING COUNTRIES;

CELLS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18;

EID: 67651037019     PISSN: 1682296X     EISSN: 16822978     Source Type: Journal    
DOI: 10.3923/biotech.2008.798.802     Document Type: Article

References (25)

1. Anderson, M., J. Handley, L. H. Wood, S. Murant, M. Stower and N. J. Maitland, 1997. Analysis of prostate tissue DNA for the presence of human papillomavirus by polymerase chain reaction, cloning and automated sequencing. J. Med. Virol., 52:8-13.
2. Bosch, F. X. and S. de Sanjose, 2002. Human papillomavirus in cervical cancer. Curr. Oncol. Rep., 4:175-183.
3. Bozzetti, M., B. Nonnenmacher, I. Mielzinska, L. Villa and A. Lorincz et al., 2000. Comparison between Hybrid Capture II and polymerase chain reaction results among women at low-risk for cervical cancer. Ann. Epidemiol, 10:466-466.
4. Cubie H. A., A. L. Seagar, E. McGoogan, J. Whitehead, A. Brass, M. J. Arends and M. W. Whitley, 2001. Rapid real-time PCR to distinguish between human papillomavirus types 16 and 18. J. Clin. Pathol. Mol. Pathol, 54:24-29.
5. Drain P. K., K. K. Holmes, J. P. Hughes and L. A. Koutsky, 2002. Determinants of cervical cancer rates in developing countries. Int. J. Cancer, 100:199-205.
6. Dyson N, M. P. Howley, K. Munger and E. D. Harlow, 2002. The human papillomavirus 16 oncoprotein is able to bind to the retinoblastoma gene products. Science, 243:934-936.
7. Griffin, N. R, D. Dockey and F. A. Lewis, 1997. Demonstration of low frequency of human papilloma virus DNA in cervical adenocarcinoma and adenocarcinoma in situ by the polymerase chain reaction and in situ hybridization Int. J. Gynecol. Pathol, 10:100-106.
8. Guerrero, E., R. W. Daniel, F. X. Bosh, X. Castellsague, M. Nubia, M. Gilli and P. Viladuli, 1992. Comparison of viral Pap, Southern hybridization and polymerase chain reaction for Human papillomavirus identification in an epidemiological investigation of cervical cancer. J. Clin. Microl., 30:2951-2959.
9. Kampion, M. J., 1992. The adequate cervical smear: A modern dilemma. J. Fam. Prac., 34:271-292.
10. Kim, Y., S. Y. Hur, T. E. Kim, J. Lee, E. S. Namkoong, I. K. Kim and J. W. Kim, 2001. Protein kinase C modulates telomerase activity in human cervical cancer cell. Exp. Mol. Med., 33:156-163.
11. Koss, L. G., 1992. Diagnostic Cytology and its Histopathologic Bases. 4th Edn. Lippincott, Philadelphia.
12. Lytwyn, A., J. W. Sellors and J. B. Mahony, 2000. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical abnormalities: A randomized trial. Can. Med. Assoc. J., 163:701-707.
13. Marybeth, W., M. J. Carmody, H. Tarraza and P. H. Calvin, 1996. Use of the polymerase chain reaction to specifically amplify integrated HPV 16 DNA virtue of its linkage to interspersed repetitive DNA. Mol. Cel Probes, 10:107-116.
14. McFadden, S. E. and L. Schumann, 2001. The role of human papillomavirus in screening for cervical cancer. J. Am. Acad. Nurse Pract., 13:116-125.
15. Molijn, A., B. Kleter, W. Quint and J. L. van Doorn, 2005. Molecular diagnosis of human papillomavirus (HPV) infections. J. Clin. Virol, 32S: S43-S51.
16. Naucler, P., F. M. Costa, O. Ljungberg, A. Bugalho and J. Dillner, 2004. Human papillomavirus genotypes in cervical cancers in Mozambique. J. General Virol, 85:2189-2190.
17. Ogunmodede, F., H. S. Yale, B. Krawisz, G. C. Tyler and A. C. Evans, 2007. Human papillomavirus infections in primary care. Clin. Med. Res., 5:210-217.
18. 7 genes induce discordant changes in the expression of cell growth regulatory proteins. Carcinogenesis, 17:1395-1401.
19. Pernoll, M. L. and R. Benson, 1987. Current Obstetrics and Gynecology Diagnosis Treatment. 10th Edn. Appleton and Lange, California, ISBN 0071439005 /9780071439008.
20. Prayitno, A., 2006. Cervical cancer with human papilloma virus and epstein barr virus positive. J. Carcinog, 5:13-13.
21. Shibata, D. K., N. Arnheim and W. S. Martin, 1988. Detection of human papillomavirus ion paraffin embedded tissue using the polymerase chain reaction. J. Exp. Med., 167:2000-2008.
22. Shin, H. R., D. H. Lee, R. Herrero, J. S. Smith, S. Vaccarella and S. H. Hong, 2003. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int. J. Cancer, 103:413-421.
23. Swygart, C., 1997. Human papilloma virus: Disease and laboratory diagnosis. Br. J. BioMed. Sci., 54:229-303.
24. Valente, P., D. Schantz and J. F. Trabal, 1996. The determination of Papanicolaou smear adequacy using a semiquantitative method to evaluate cellularity. Diagnostic Cytopathol., 7:576-586.
25. Young, L. S., I. S. Bevan, M. A. Johnson, P. I. Blomfield, T. Bromidge, N. J. Maitland and C. B. J. Woodman, 1989. The polymerase chain reaction: A new epidemiological tool for investigating cervical human papillomavirus infection. BMJ., 298:14-18.